This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Transforming Cancer Diagnosis
- Used by pathologists in everyday practice
- Clinical grade accuracy
- Improved productivity and shorter turnaround time
- Reduced error rate and 100% quality control
- AI-based diagnostic tools: case prioritization worklist, slide viewer, IHC preordering, cancer heatmaps, grading, measurements, non-cancer findings, AI-driven reporting
Gastric cancer is among the most common malignant diseases in both men and women worldwide, with over a million new cases each year. Accurate and timely diagnosis is instrumental in guiding treatment decisions and improving survival rates.
However, accurate and rapid analysis of gastric biopsies remains a challenge, as increasing case volumes are intensified by subjectivity in detecting cancer, low percentage of cancer vs. benign cases, difficulty in detecting H. pylori and multiple other reasons.
Powered by AI and serving the world’s leading physicians, health systems
and diagnostic providers, Galen™ Gastric is a clinical-grade solution that assists pathologists in improving the detection of gastric cancer and other clinical findings.
H. pylori related gastritis heatmap
Lymphomas heatmap
Neuroendocrine neoplasms heatmap
Podcasts
Listen to this podcast with Ibex’s CTO, Dr. Chaim Linhart, discussing the unique challenges and opportunities for unlocking the tools of digital pathology.
Galen™ Gastric is CE marked (IVDD). Galen Gastric is for Research Use Only (RUO) in the United States and not cleared by the FDA. Contact us for more information, including indication for use and regulatory approval in other countries.